Embecta Corp.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 1.17B | 1.13B | 1.12B | 1.12B | 1.08B | -3.8% | |
| Cost of Revenue | (365.00M) | (354.60M) | (370.90M) | (394.20M) | (400.90M) | 1.7% | |
Gross Profit | 800.00M | 774.90M | 749.90M | 728.90M | 679.50M | -6.8% | |
| Operating Expenses | |||||||
| Research & Development | (63.00M) | (65.00M) | (85.20M) | (78.80M) | (21.50M) | -72.7% | |
| Selling, General & Administrative | (240.30M) | (294.80M) | (341.30M) | (365.10M) | (331.40M) | -9.2% | |
| Depreciation & Amortization | (38.00M) | (31.70M) | (32.70M) | (42.50M) | (51.10M) | 20.2% | |
Operating Income (EBIT) | 492.00M | 378.10M | 229.60M | 174.20M | 329.30M | 89.0% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | — | (46.20M) | (107.00M) | (112.30M) | (107.30M) | -4.5% | |
| Other Income/Expenses (Net) | 3.00M | -121.50M | -123.90M | -130.00M | -193.00M | 48.5% | |
Income Before Tax | 495.00M | 256.60M | 105.70M | 44.20M | 136.30M | 208.4% | |
| Income Tax Expense | (80.00M) | (33.00M) | (35.30M) | (34.10M) | (40.90M) | -219.9% | |
Net Income | 414.80M | 223.60M | 70.40M | 78.30M | 95.40M | 21.8% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $7 | $4 | $1 | $1 | $2 | 22.4% | |
| Weighted Avg Shares Outstanding | 56.80M | 57.06M | 57.24M | 58.33M | 58.31M | -0.0% | |
| Weighted Avg Shares Outstanding (Diluted) | 56.80M | 57.06M | 57.76M | 58.33M | 58.91M | 1.0% | |
EBITDA | 533.00M | 334.50M | 245.40M | 199.00M | 294.70M | 48.1% |
Explore EMBC
EMBC in the Healthcare
Small Cap